Friday - March 27, 2026

DTC Production Company Returns with Award-Winning Thriller/Drama “Deadly Retreat” – Now Streaming on Multiple Platforms

DTC Production Company, of Loganville, GA, renowned for their exceptional storytelling and innovative filmmaking, has once again raised the bar with their latest award-winning project, “Deadly Retreat”. This gripping Thriller/Drama, written and directed by Catina R. Fletcher and Denisha Brown­ … Continue reading

Urothelial Carcinoma Market on Track for Major Expansion by 2034, According to DelveInsight | Infinity, QED Therapeutics, BeiGene, Eli Lilly, Roche, UroGen, NektarTherapeutics, BMS, Incyte, Abbisko

The Key Urothelial Carcinoma Companies in the market include – Merck, Bristol Myers Squibb, Bicycle Therapeutics, Infinity, QED Therapeutics, BeiGene, Eli Lilly, Roche, UroGen, Nektar Therapeutics, BMS, Incyte, Abbisko, Mamta Parikh, AstraZeneca, Janssen Research & Development, LLC, Pfizer, Inovio Pharmaceuticals, … Continue reading

Vascular Dementia Market Growth Projections 2024-2034: DelveInsight Analysis | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP

The Key Vascular Dementia Companies in the market include – Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP Pharma, Johnson & Johnson, Materia Medica Holding, Eisai Co., Ltd., Shineway Pharma, Merz Pharma, Ever Neuro Pharma GmbH, Zhejiang Otsuka Pharma, … Continue reading

Artificial Intelligence in Cybersecurity Market Recent Trends, Outlook, Size, Share, Top Companies, Industry Analysis, Future Development & Forecast – 2028

NVIDIA (US), Intel (US), Xilinx Inc. (US), Samsung Electronics Co., Ltd (South Korea), Micron Technology, Inc. (US), IBM Corporation (US), Amazon Web Services, Inc. (US), Microsoft (US), Palo Alto Networks Inc. (US), Trellix (US), CrowdStrike (US), NortonLifeLock (US), Cylance Inc. … Continue reading

COPD Clinical Trials Pipeline 2025: COPD FDA Approvals, Therapy Innovations, and Emerging Landscape Analysis by DelveInsight | Amgen, Synairgen, AstraZeneca, Sanofi, Organicell Regenerative Medicine

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Obstructive Pulmonary Disease pipeline constitutes 65+ key companies continuously working towards developing 70+ Chronic Obstructive Pulmonary Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading

Myasthenia Gravis Market Expected to Witness Substantial Growth by 2034, Driven by Recent FDA Approvals and Positive Clinical Trial Outcomes | DelveInsight

Myasthenia Gravis – Market Insight, Epidemiology And Market Forecast – 2034 The Myasthenia Gravis treatment market is projected to experience significant expansion in the coming years, propelled by the development of innovative therapies from key myasthenia gravis companies including Horizon … Continue reading

Migraine Market Size Projected to Grow Rapidly by 2034, Driven by Recent FDA Approvals and Emerging Therapies | DelveInsight

Migraine Market Insight, Epidemiology And Market Forecast – 2034 The migraine therapeutics market is experiencing robust growth. Key migraine companies, including Lundbeck Seattle BioPharmaceutical, Eli Lilly and Company, Amgen, Novartis, Teva Pharmaceuticals, Biohaven Pharmaceuticals, Dr. Reddy’s Labs, AbbVie, Impel NeuroPharma, … Continue reading

Hormone Replacement Therapy Market Set to Grow at a Robust CAGR of 6.5% Through 2030, Fueled by Rising Menopausal Population and Novel Treatment Approaches | DelveInsight

Hormone Replacement Therapy Market Report Key hormone replacement therapy companies include Abbott, Novartis AG, Pfizer Inc., Merck KGaA, Bayer AG, Halozyme Therapeutics, Eli Lilly and Company, Viatris Inc., F. Hoffman-La Roche, Novo Nordisk A/S, Amgen Inc., AbbVie Inc., Teva Pharmaceutical … Continue reading

Congestive Heart Failure Market Poised for Substantial Growth by 2034, Driven by Emerging Cell Therapies and Recent FDA Approvals | DelveInsight

Congestive Heart Failure Market Report The congestive heart failure therapeutics market is projected to witness substantial growth driven by rising prevalence, technological advancements, and innovative treatment options. Key pharmaceutical companies, including Novartis, Alnylam, Otsuka, AstraZeneca, Bayer, Novo Nordisk, Boehringer Ingelheim, … Continue reading